Risk of fetal mosaicism when placental mosaicism is diagnosed by chorionic villus sampling

Am J Obstet Gynecol. 1996 Mar;174(3):850-5. doi: 10.1016/s0002-9378(96)70312-5.

Abstract

Objective: Our purpose was to determine the risk of fetal mosaicism when placental mosaicism is found on chorionic villus sampling.

Study design: We present a case of mosaic trisomy 22 detected on chorionic villus sampling and subsequently found in the fetus. A review of comprehensive chorionic villus sampling studies with emphasis on follow-up for fetal mosaicism was conducted.

Results: Among 13 studies reviewed, 469 cases of placental mosaicism are presented; fetal mosaicism was found in 50 (10.7%). Factors associated with fetal mosaicism are (1) mosaicism on mesenchymal core culture and (2) type of chromosome abnormality involved--specifically, marker chromosomes (26.7%) and common autosomal trisomies (19.0%). Amniocentesis predicted fetal genotype in 93% to 100% of cases of placental mosaicism, depending on the cell type in which mosaicism was diagnosed.

Conclusions: Although mosaicism is usually confined to the placenta, the fetus is involved in about 10% cases. Patients should be counseled about this risk and the accuracy of follow-up amniocentesis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Amniocentesis
  • Chorionic Villi Sampling
  • Chromosomes, Human, Pair 22*
  • Female
  • Fetal Diseases / diagnosis
  • Fetal Diseases / genetics*
  • Humans
  • Mosaicism*
  • Placenta / pathology*
  • Pregnancy
  • Risk Factors
  • Trisomy*